YAG
CELU icon

Yorkville Advisors Global’s Celularity CELU Stock Holding History

Yorkville Advisors Global’s Portfolio CELU Stock Details CELU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100,000
Closed -$207K – 33
2025
Q3 		$207K Sell
100,000
-100,000
-50% -$280K 0.08% 23
2025
Q2 		$392K Buy
+200,000
New +$364K 0.11% 11

Other funds holding CELU

CVSC
C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VA
Valmark Advisers Akron, Ohio $9.42B AUM 17.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

Yorkville Advisors Global's CELU Position: Q4 2025 in Review

Yorkville Advisors Global sold out of Celularity (CELU) in Q4 2025, closing a stake of 100,000 shares — an estimated $207K sold.

Yorkville Advisors Global first reported a position in CELU in Q2 2025 and held it in 2 quarters. The position peaked at $392K in Q2 2025. 36 funds tracked by Wall St. Rank hold CELU as of Q4 2025.

  • Yorkville Advisors Global reported no remaining Celularity position as of Q4 2025 after selling out during the quarter.
  • Yorkville Advisors Global sold 100,000 Celularity shares in Q4 2025, an estimated $207K.
  • Yorkville Advisors Global first reported a position in Celularity in Q2 2025 and held it in 2 quarters.
  • Yorkville Advisors Global's Celularity position peaked at $392K in Q2 2025.
  • 36 funds tracked by Wall St. Rank held Celularity as of Q4 2025.

Based on Yorkville Advisors Global's 13F filing for Q4 2025, filed 10 Feb 2026.